Internal Medicine, Hematology & Oncology · Cleveland, OH
NPI
1871841908
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
11100 Euclid Ave
Cleveland, OH, 44106
Phone (312) 513-7437
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
657 services
Medicare patients, 2024
167
Average age 73
Drug cost, 2024
$2.0M
450 prescriptions
Company payments, 2025
$25K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ankit Mangla was code 99215 (office e&m - established), 352 times for 107 patients. In total Ankit Mangla billed 657 services in 16 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 352 | 107 | $106.00 | $37K |
| 99443 Telephone Services | Facility | 82 | 44 | $70.23 | $5,759 |
| 99205 Office E&M - New | Facility | 54 | 54 | $129.13 | $6,973 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 52 | 39 | $12.53 | $652 |
| 99233 Hospital E&M - Subsequent | Facility | 51 | 19 | $81.62 | $4,163 |
| 99214 Office E&M - Established | Facility | 28 | 22 | $71.16 | $1,993 |
By year: 2022 $48K for 497 services; 2023 $48K for 505 services; 2024 $60K for 657 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ankit Mangla prescribed most often to Medicare patients was Prednisone, with 68 prescriptions and refills. In total Ankit Mangla wrote 450 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 68 | 92 | 31 | $430 |
| Mektovi Binimetinib | 33 | 33 | Under 11 | $449K |
| Braftovi Encorafenib | 32 | 32 | Under 11 | $544K |
| Ondansetron Hcl Generic | 27 | 29 | 19 | $3,079 |
| Levothyroxine Sodium Generic | 26 | 38 | Under 11 | $220 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 21 | 24 | Under 11 | $52.31 |
| Gabapentin Generic | 15 | 19 | Under 11 | $191 |
| Ibrance Palbociclib | 15 | 15 | Under 11 | $240K |
| Eliquis Apixaban | 14 | 26 | Under 11 | $15K |
| Triamcinolone Acetonide Generic | 13 | 15 | Under 11 | $59.16 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 11 | 11 | Under 11 | $203 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 11 | 13 | Under 11 | $165 |
Brand drugs: 118 claims; generic drugs: 332 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ankit Mangla $25K ($16K in general payments such as food, travel and fees and $8,566 for research) from 9 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $12K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.